Published on 22/12/2025
Addressing Adherence Challenges in Pediatric and Geriatric Clinical Trials
Introduction to Adherence in Age-Specific Trials
Adherence, or compliance, refers to how closely participants follow the prescribed regimen in a clinical trial, including taking medications, attending visits, and following lifestyle instructions. In pediatric and geriatric trials, adherence is particularly challenging due to age-related factors such as dependence on caregivers, cognitive limitations, comorbidities, and lifestyle constraints. Poor adherence can compromise data integrity, reduce statistical power, and lead to inaccurate conclusions about safety and efficacy.
For example, in pediatric asthma trials, adherence may be affected by a child’s dislike of inhalers, while in geriatric hypertension trials, polypharmacy and memory decline may contribute to missed doses. Sponsors must design trials with adherence strategies embedded from the outset to ensure reliable results.
Unique Adherence Challenges in Pediatric Trials
Pediatric participants often rely entirely on parents or guardians for medication administration and appointment attendance. This dependence introduces variability based on caregiver availability, health literacy, and motivation. Taste, texture, and formulation of medication also play a major role in pediatric adherence—unpleasant taste can significantly lower compliance rates.
Children’s school schedules, extracurricular activities, and developmental stage can further influence adherence. For
Adherence Challenges in Geriatric Trials
In elderly participants, adherence can be affected by cognitive impairment, sensory deficits (vision, hearing), and physical limitations such as arthritis. Comorbid conditions often lead to polypharmacy, increasing the complexity of dosing regimens and raising the risk of drug–drug interactions. Elderly participants may also experience transportation challenges, limiting their ability to attend trial visits.
Trial protocols should account for these challenges by minimizing pill burden, providing clear instructions in large print, and offering home visits or telemedicine options where possible.
Role of Caregivers in Supporting Adherence
Caregivers play a pivotal role in both pediatric and geriatric trials. In pediatrics, caregivers ensure correct dosing, maintain dosing diaries, and liaise with trial staff. In geriatrics, caregivers may assist with medication management, appointment scheduling, and symptom reporting. Training caregivers on trial protocols, potential side effects, and the importance of adherence is critical for trial success.
Providing caregiver-friendly materials—such as illustrated dosing guides or video instructions—can enhance understanding and improve compliance rates.
Table: Comparison of Adherence Challenges by Age Group
| Factor | Pediatric | Geriatric |
|---|---|---|
| Dependence on others | High (parents/guardians) | High (family, caregivers) |
| Cognitive limitations | Developmental stage | Dementia, memory loss |
| Polypharmacy | Low | High |
| Formulation issues | Taste, swallowing difficulty | Swallowing difficulty, dexterity issues |
| Visit attendance | School schedule conflicts | Mobility/transport barriers |
Regulatory Expectations on Adherence Data
Regulators such as the EMA and FDA expect adherence to be actively monitored and reported in clinical trials. The International Council for Harmonisation (ICH) guidelines recommend the use of objective adherence measures where feasible, such as electronic pill caps, biomarker confirmation, or medication diaries verified at site visits.
Non-adherence should be documented with reasons, and trial analyses may include sensitivity assessments excluding non-adherent participants to evaluate robustness of results.
Adherence Monitoring Methods
Monitoring adherence can be achieved through various tools and approaches:
- Electronic medication monitoring devices (e.g., smart pill bottles)
- Caregiver-reported dosing diaries
- Directly observed therapy (DOT)
- Biomarker-based adherence verification
- Mobile health applications with reminders
Combining objective and subjective measures provides a more complete picture of adherence behavior and enables timely interventions.
Strategies to Improve Adherence in Pediatric Trials
To address adherence challenges in pediatric trials, strategies should focus on making participation easier and more engaging for both children and caregivers. These may include:
- Using flavored liquid formulations or dispersible tablets to improve palatability
- Offering age-appropriate education about the trial’s purpose
- Providing small incentives, such as certificates or stickers, for participation milestones
- Coordinating visit schedules to avoid conflicts with school or extracurricular activities
- Implementing caregiver training sessions on correct dosing and symptom monitoring
For example, a pediatric epilepsy trial improved adherence from 75% to 92% by introducing a mobile app with animated medication reminders tailored to children’s preferences.
Strategies to Improve Adherence in Geriatric Trials
In geriatric trials, adherence strategies should minimize complexity and support participants with cognitive or physical limitations. Recommended approaches include:
- Reducing dosing frequency (e.g., once-daily formulations)
- Providing large-print medication instructions
- Using blister packs with clearly labeled days and times
- Arranging for home health visits or telemedicine follow-ups
- Involving caregivers in all trial communications
A hypertension trial in elderly participants increased adherence rates by 18% after switching from twice-daily to once-daily dosing and providing automated phone reminders.
Technology in Adherence Improvement
Digital tools have transformed adherence monitoring and support. Smartphone applications, SMS reminders, and wearable devices can track medication intake and prompt participants at scheduled times. In pediatric trials, gamified adherence tracking has proven effective, while in geriatrics, voice-assisted reminders integrated into smart home devices offer convenience and accessibility.
Integration of adherence data into the trial database allows real-time monitoring and rapid intervention in cases of declining compliance.
Case Study: Adherence in a Long-Term Pediatric Oncology Trial
In a 24-month pediatric leukemia trial, adherence to oral maintenance therapy was initially 68%. Through caregiver workshops, monthly check-in calls, and the introduction of child-friendly medication calendars, adherence increased to 90% by the 6-month mark and remained stable for the trial duration. This intervention not only improved treatment outcomes but also reduced protocol deviations.
Case Study: Geriatric Heart Failure Trial
A geriatric heart failure trial faced adherence challenges due to pill burden and mobility issues. Investigators introduced weekly home visits by trial nurses, simplified the regimen to a fixed-dose combination pill, and provided large-print dosing instructions. Adherence rates improved from 70% to 88%, and trial retention increased significantly.
Ethical and Cultural Considerations
Trial designers must consider ethical and cultural factors that affect adherence. In some cultures, deference to medical authority may lead to over-reporting of adherence, while in others, skepticism about clinical trials may lower participation. Addressing these factors through culturally sensitive education and community engagement can improve adherence and trust.
Conclusion
Adherence is a critical determinant of trial validity, particularly in pediatric and geriatric populations. By understanding age-specific challenges and implementing targeted strategies, sponsors can enhance compliance, improve data quality, and ensure participant safety. The integration of technology, caregiver involvement, and culturally sensitive communication will be key to overcoming adherence barriers in future clinical trials.